Two Sigma Securities »

Xilio Therapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2024-06-30 $13k 13k 0.95

More positions owned by Two Sigma Securities

NVIDIA Corporation Call Option (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Advanced Micro Devices (AMD)
Microsoft Corporation Call Option (MSFT)
Intel Corporation Call Option (INTC)
Eli Lilly & Co. Call Option (LLY)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Palo Alto Networks Call Option (PANW)
Chevron Corporation Call Option (CVX)
Amazon (AMZN)
Costco Wholesale Corporation Call Option (COST)

View all positions for Two Sigma Securities

Top funds holding Xilio Therapeutics

Bain Capital Life Sciences Investors
Rock Springs Capital Management
RiverVest Venture Management
Morgan Stanley
Vanguard Group
Geode Capital Management
Balyasny Asset Management
Renaissance Technologies
BlackRock
Bridgeway Capital Management
BlackRock
State Street Corporation
SevenBridge Financial
Northern Trust
Raymond James & Associates

View all funds holding Xilio Therapeutics